[EN] CYCLOHEXANE ACID DERIVATIVES AS LPA RECEPTOR INHIBITORS<br/>[FR] DÉRIVÉS D'ACIDE CYCLOHEXANE UTILISÉS EN TANT QU'INHIBITEURS DU RÉCEPTEUR DE LPA
申请人:[en]CHIESI FARMACEUTICI S.P.A.
公开号:WO2023118253A1
公开(公告)日:2023-06-29
The present invention relates to a compounds of general formula (I) inhibiting lysophosphatidic acid receptor 1 (LPA1), particularly the invention relates to compounds that are cyclohexane acid derivatives, methods of preparing such compounds, pharmaceutical compositions containing them and therapeutic use thereof. The compounds of the invention may be useful in the treatment of diseases or conditions associated with a dysregulation of LPA receptors, in particular fibrosis.
Efficient synthesis of pyrazine boronic esters via palladium-catalyzed Miyaura borylation
A facile and efficient protocol for palladium-catalyzed Miyaura borylation reaction of chloropyrazines with B2pin2 has been developed. A certain range of difficult-to-access pyrazine boronic esters can be easily prepared from the corresponding chloropyrazines in moderate to good yields.
[EN] CTPS1 INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE CTPS1 ET LEURS UTILISATIONS
申请人:NIMBUS CLOTHO INC
公开号:WO2022087634A1
公开(公告)日:2022-04-28
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of CPTS1, and the treatment of CPTS1-mediated disorders.